How Hepatitis C Virus Regulates Desmosterol to Affect RNA Replication: a New Virus-Host Interaction

丙型肝炎病毒如何调节去莫甾醇影响 RNA 复制:一种新的病毒-宿主相互作用

基本信息

  • 批准号:
    10433794
  • 负责人:
  • 金额:
    $ 23.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-01 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

The importance of lipid membranes in the replication of RNA viruses is widely appreciated, yet our understanding of their precise chemical composition and function in this process remains poorly understood. While many studies have been able to document virus-induced changes in the expression of host enzymes responsible for lipid biosynthesis and metabolism, few studies have been able to translate these findings into chemical knowledge of the lipid species present in the membranes where RNA replication occurs, how the virus assembles this specialized membrane, how particular lipids dictate the biochemical and biophysical properties of these membranes, and how these properties in turn affect viral RNA replication. We discovered that hepatitis C virus (HCV) alters the abundance of desmosterol, a penultimate intermediate in cholesterol biosynthesis, and causes it to localize in the specialized membranes where RNA replication occurs. Depletion of desmosterol from the cell has a significant antiviral effect due to decreased steady-state RNA replication. Rescue of this effect by exogenous desmosterol cannot be fully recapitulated by cholesterol. Based on these findings, we have proposed a model in which desmosterol localized in the replication membrane is important for efficient RNA replication, and HCV perturbs the cholesterol biosynthetic pathway to promote accumulation of desmosterol at this locale. Here, we propose Aims designed to elucidate the unique mechanism(s) whereby HCV alters desmosterol homeostasis and to establish experimental systems that allow us to interrogate the effects of specific lipids on HCV RNA replication under chemically defined conditions. In Aim 1, we will probe the mechanisms by which HCV affects desmosterol homeostasis, focusing on HCV’s effects on DHCR24, the enzyme that converts desmosterol to cholesterol. We recently found that a post-translationally modified form of DHCR24 appears in HCV-infected cells and that the active NS3-4A protease is sufficient to generate this species. We have mapped the likely cleavage site near the N- terminus of the protein. Therefore, in Aim 1, we will examine whether this cleavage event affects the enzymatic activity, stability, or localization of DHCR24. In Aim 2, we will develop proteoliposome and supported lipid bilayer systems as models in which we can study the active HCV replicase within a membrane whose lipid content we can control and study. Since desmosterol differs from cholesterol only by the presence of an alkene at carbon 24, its distinct effects on HCV replication are an intriguing example that even seemingly subtle changes in lipid structure may have profound effects on membrane-associated biological processes. HCV’s mechanism for tuning lipid content in the membrane where replication occurs constitutes a novel class of virus-host interactions.
脂质膜在RNA病毒复制中的重要性得到了广泛的认识,但是我们对它们在这一过程中的精确化学组成和功能的理解仍然很少了解。 While many studies have been able to document virus-induced changes in the expression of host enzymes responsible for lipid biosynthesis and metabolism, few studies have been able to translate these findings into chemical knowledge of the lipid species present in the membranes where RNA replication occurs, how the virus assembles this specialized membrane, how particular lipids dictate the biochemical and biophysical properties of these membranes, and这些特性又如何影响病毒RNA复制。我们发现丙型肝炎病毒(HCV)改变了胆固醇生物合成中倒数第二个中间体的抽象,并导致其定位在发生RNA复制的专用膜中。由于稳态RNA的复制减少,从细胞中耗尽了Desmasterol的抗病毒作用显着。胆固醇不能完全概括外源性去甲醇来挽救这种作用。基于这些发现,我们提出了一个模型,在该模型中,在复制膜中定位的desmasterol对于有效的RNA复制很重要,而HCV伴随着胆固醇生物合成途径,以促进Desmasterol在该网站上的积累。在这里,我们提出的目的旨在阐明HCV改变desmasterol稳态的独特机制,并建立实验系统,使我们能够在化学定义的条件下询问特定脂质对HCV RNA复制的影响。在AIM 1中,我们将探测HCV影响desmasterol稳态的机制,重点是HCV对DHCR24的影响,DHCR24是将desmasterol转化为胆固醇的酶。我们最近发现,在HCV感染的细胞中出现了跨化后修饰的DHCR24形式,并且活性NS3-4A蛋白酶足以生成该物种。我们已经绘制了蛋白质N末端附近的可能性切割位点。因此,在AIM 1中,我们将检查该裂解事件是否影响DHCR24的酶活性,稳定性或定位。在AIM 2中,我们将开发蛋白脂质体和支持的脂质双层系统,作为模型,我们可以在该模型中研究我们可以控制和研究的脂质含量的膜中的活性HCV复制酶。由于仅通过碳24处的烯烃存在与胆固醇的不同之处,因此其对HCV复制的独特作用是一个有趣的例子,即即使是脂质结构看似微妙的变化,也可能对膜相关的生物学过程产生深远的影响。 HCV在复制发生的膜上调整脂质含量的机制构成了一种新型的病毒宿主相互作用。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Priscilla Li-ning Yang其他文献

Priscilla Li-ning Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Priscilla Li-ning Yang', 18)}}的其他基金

Small molecule inhibitors and degraders of picornavirus 2A proteases as direct-acting antivirals
小核糖核酸病毒 2A 蛋白酶的小分子抑制剂和降解剂作为直接抗病毒药物
  • 批准号:
    10514272
  • 财政年份:
    2022
  • 资助金额:
    $ 23.62万
  • 项目类别:
How Hepatitis C Virus Regulates Desmosterol to Affect RNA Replication: a New Virus-Host Interaction
丙型肝炎病毒如何调节去莫甾醇影响 RNA 复制:一种新的病毒-宿主相互作用
  • 批准号:
    10078255
  • 财政年份:
    2020
  • 资助金额:
    $ 23.62万
  • 项目类别:
Small molecule degraders of HIV-1 Nef
HIV-1 Nef 的小分子降解剂
  • 批准号:
    10414395
  • 财政年份:
    2020
  • 资助金额:
    $ 23.62万
  • 项目类别:
Small molecule degraders of HIV-1 Nef
HIV-1 Nef 的小分子降解剂
  • 批准号:
    10297863
  • 财政年份:
    2020
  • 资助金额:
    $ 23.62万
  • 项目类别:
Chemical Tools for the Study of Dengue Virus Entry
用于研究登革热病毒侵入的化学工具
  • 批准号:
    8337072
  • 财政年份:
    2011
  • 资助金额:
    $ 23.62万
  • 项目类别:
Directed Evolution of a Murine Model of Hepatitis C Virus Replication
丙型肝炎病毒复制小鼠模型的定向进化
  • 批准号:
    7825454
  • 财政年份:
    2009
  • 资助金额:
    $ 23.62万
  • 项目类别:
Validation of Src kinases as Anti-Dengue Viral Targets
验证 Src 激酶作为抗登革热病毒靶点
  • 批准号:
    7634494
  • 财政年份:
    2008
  • 资助金额:
    $ 23.62万
  • 项目类别:
Validation of Src kinases as Anti-Dengue Viral Targets
验证 Src 激酶作为抗登革热病毒靶点
  • 批准号:
    7533684
  • 财政年份:
    2008
  • 资助金额:
    $ 23.62万
  • 项目类别:
Validation of Src kinases as Anti-Dengue Viral Targets
验证 Src 激酶作为抗登革热病毒靶点
  • 批准号:
    8264956
  • 财政年份:
    2008
  • 资助金额:
    $ 23.62万
  • 项目类别:
Validation of Src kinases as Anti-Dengue Viral Targets
验证 Src 激酶作为抗登革热病毒靶点
  • 批准号:
    8073067
  • 财政年份:
    2008
  • 资助金额:
    $ 23.62万
  • 项目类别:

相似国自然基金

“蜂巢催化”高碳烯烃氢甲酰化反应中的基础问题研究
  • 批准号:
    22372188
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
MOFs孔环境精细化调控及其低碳烷烃/烯烃分离性能研究
  • 批准号:
    22371226
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于烯烃环氧化用的负载型多级孔Ti-MWW分子筛的构筑和调控机制研究
  • 批准号:
    22368025
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
构筑碳基Fe3O4-FeCx异质结催化CO2加氢合成烯烃的机制研究
  • 批准号:
    42377249
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
绿氢绿氧耦合煤制烯烃系统集成与多目标鲁棒优化研究
  • 批准号:
    22308242
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

How Hepatitis C Virus Regulates Desmosterol to Affect RNA Replication: a New Virus-Host Interaction
丙型肝炎病毒如何调节去莫甾醇影响 RNA 复制:一种新的病毒-宿主相互作用
  • 批准号:
    10078255
  • 财政年份:
    2020
  • 资助金额:
    $ 23.62万
  • 项目类别:
Biocatalytic Methods for the Asymmetric Synthesis of Amines
胺不对称合成的生物催化方法
  • 批准号:
    9760580
  • 财政年份:
    2019
  • 资助金额:
    $ 23.62万
  • 项目类别:
Cyclization Cascades to Access Bioactive Diterpenoids
环化级联以获得生物活性二萜类化合物
  • 批准号:
    9753289
  • 财政年份:
    2018
  • 资助金额:
    $ 23.62万
  • 项目类别:
Cyclization Cascades to Access Bioactive Diterpenoids
环化级联以获得生物活性二萜类化合物
  • 批准号:
    10217197
  • 财政年份:
    2018
  • 资助金额:
    $ 23.62万
  • 项目类别:
Asymmetric Synthesis of Macrolide Antibiotics
大环内酯类抗生素的不对称合成
  • 批准号:
    7863511
  • 财政年份:
    2009
  • 资助金额:
    $ 23.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了